RefiningValue.bsky.social
Health economist writing about HEOR/market access, drug development, biopharma
Http://refiningvalue.substack.com
Starter Packs
Created by RefiningValue.bsky.social (1)
HEOR
Health Economics & Outcomes Research professionals
@ashjogalekar.bsky.social
I write about medicinal and computational chemistry and drug discovery with a sprinkling of history. Blog at medchemash.substack.com.
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@araymakers.bsky.social
Health economist & research fellow with the Program on Regulation, Therapeutics, & Law (PORTAL) at Harvard Medical School. Interests: drug pricing/policy, health technology assessment, climate change. Squamish, BC www.linkedin.com/in/araymakers
@akesselheim.bsky.social
Professor of Medicine, Brigham and Women's Hospital/Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL)
@robcaliff.bsky.social
@tradeoffs.org
Journalism that explores the complicated, costly, and often counterintuitive world of health care. New podcast episodes every Thursday, hosted by Dan Gorenstein. Subscribe to our weekly newsletter: tradeoffs.org/subscribe
@tuftscevr.bsky.social
Center for the Evaluation of Value and Risk in Health at Medical Center. Posts and reposts are not endorsements. https://cevr.tuftsmedicalcenter.org/
@jdwilko.bsky.social
Centre for Biostatistics, Uni of Manchester. Currently developing INSPECT-SR, a tool to identify problematic clinical trials. Research misconduct, fertility research. Own opinions.
@prof-nancy-devlin.bsky.social
Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans.
@jrboehnke.bsky.social
I work at the School of #HealthSciences, University of Dundee Interested in measurement, (health-related) quality of life #HRQL, multimorbidity, #ResearchEthics, publishing models, #PeerReview & research assessment Ex- #REF2021 & former #NightshiftEditor
@georgevaliotis.bsky.social
Executive Director of HTAi. The intersection of health and human rights. Wellbeing and Art.
@kellyahan.bsky.social
Director, Global HTA Initiatives at ISPOR | MPH Epi | ❤ #HTA #HEOR #healthcare #publichealth #LMICs #ISPORian #travel | Tweets are mine only
@peterneumann11.bsky.social
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@drugchannels.bsky.social
President, Drug Channels Institute, an HMP Global company Please be civil and constructive when commenting. Personal attacks = blocked.
@aciaccia.bsky.social
Advocate for drug price transparency, competitive healthcare markets, & patient-centered care at 46brooklyn Research and 3 Axis Advisors. Dad to Franco, Marco, Vera, Enzo.
@sisyphus55.bsky.social
YouTuber: https://www.youtube.com/@Sisyphus55 PhD student in Clinical Psychology: https://orcid.org/0000-0002-4556-1448
@downtownjoshbrown.bsky.social
Investor, CEO, Dad https://www.downtownjoshbrown.com/
@abfriedman.com
This is my personal account. Faculty at UPenn. Emergency doc, health economist, geriatrics and privacy researcher. Views are my own. RT does not imply endorsement.
@jcubanski.bsky.social
Medicare expert. Deputy Director, Program on Medicare Policy @KFF. Part D, prescription drug policy, Medicare spending & financing, cyclist, NYT spelling bee fanatic.
@jcranmer.bsky.social
Executive Editor, BioCentury. Host, BioCentury This Week biotech podcast. Jersey Boy happily ensconced in Cali. Princeton. SAIS. Philly Eagles. Opinions=my own.
@stephenhansen.bsky.social
Dad of 2 exhausting boys. Director of Biopharma Intelligence BioCentury. Covers biotech. Home in the UK, roots in MN. #SKOL iykyk stephenhansenimages.zenfolio.com
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@neilirwin.bsky.social
Chief Economic Correspondent at Axios. Author of daily Axios Macro newsletter. Author of "The Alchemists." Formerly: NYT, WashPost.
@sahilkapur.bsky.social
NBC News Senior National Political Reporter covering Capitol Hill and elections 🏛️🗳️ Part-time Formula 1 correspondent. 🏁🏎️ https://x.com/sahilkapur
@timduy.bsky.social
Husband, father, Chief U.S. Economist, @sghmacro, @uoregon economist, Tim Duy's Fed Watch, former columnist for @bopinion
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@arsalan.endpoints.news
Founder/CEO of Endpoints News (acquired by the Financial Times). Lawrence, Kansas-based aviator. Sharing occasional biopharma news biz takes and cockpit views. @AKAarsalan on twitter
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@brianreid.bsky.social
I have a newsletter. It's called Cost Curve. I write a lot about dull things like 340B reform and benefit design and the Value Flower. You can probably Google it.
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@gregmedlock.bsky.social
Interested in drug development, microbial ecology, systems biology, & urbanism. I develop bacterial consortia as drugs: https://www.vedantabio.com
@rowanwalrath.bsky.social
Life sciences reporter @cenmag.bsky.social. Texan Bostonian. Vaxed & masked. she/her. r_walrath@acs.org. For sensitive tips, I'm on Signal @rowanwalrath.01 or email rowan.walrath@proton.me
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨